e-Article
The use of 18 F-Fluoro-deoxy-glucose positron emission tomography (18 F-FDG PET) as a non-invasive pharmacodynamic biomarker to determine the minimally pharmacologically active dose of AZD8835, a novel PI3Kα inhibitor
Document Type
Article
Author
Source
In: PLoS ONE . (PLoS ONE, August 2017, 12(8))
Subject
Language
English
ISSN
19326203